Control of ruminant morbillivirus replication by small interfering RNA

Area of Science:

• Veterinary Virology
• Molecular Biology
• RNA Therapeutics

Background:

• Peste-des-petits-ruminants virus (PPRV) and rinderpest virus (RPV) are economically significant morbilliviruses affecting livestock in Africa and Asia.
• Current vaccines for PPRV and RPV offer protection only after 14 days, necessitating alternative emergency control measures.
• There is a need for effective therapeutic strategies to manage PPRV and RPV outbreaks rapidly.

Purpose of the Study:

• To identify and validate target regions within PPRV and RPV nucleocapsid genes for RNA interference therapy.
• To evaluate the efficacy of synthetic short interfering RNAs (siRNAs) in reducing PPRV and RPV replication.
• To explore the potential of siRNA as a therapeutic agent against PPRV and RPV infections.

Main Methods:

• Identification of conserved target sequences in the nucleocapsid genes of PPRV and RPV.
• Synthesis and application of short interfering RNAs (siRNAs) targeting these regions.
• Quantification of viral RNA reduction using real-time quantitative PCR.
• Assessment of viral protein and particle reduction via flow cytometry, cytopathic effect, and virus titration.

Main Results:

• Two specific regions in the nucleocapsid genes of PPRV and RPV were identified as effective siRNA targets.
• siRNA treatment resulted in a significant reduction of viral RNA, viral proteins, and infectious virus particles (>80% reduction).
• The study demonstrated the potent antiviral activity of siRNAs against both PPRV and RPV in vitro.

Conclusions:

• Synthetic siRNAs targeting specific nucleocapsid gene regions are highly effective in inhibiting PPRV and RPV replication.
• siRNA molecules hold significant potential for development into therapeutic agents for PPRV and RPV infections.
• This research provides a foundation for developing novel RNA-based treatments for morbillivirus diseases in livestock.